DOI:
10.1055/s-00035024
Thrombosis and Haemostasis
LinksClose Window
References
Al-Aieshy F, Malmström RE, Antovic J. , et al.
Clinical evaluation of laboratory methods to monitor exposure of rivaroxaban at trough and peak in patients with atrial fibrillation.
Eur J Clin Pharmacol 2016;
72 (06) 671-679
We do not assume any responsibility for the contents of the web pages of other providers.